Why Grail Stock Soared 14% Higher on Thursday
Key Points
The cancer diagnostics specialist inked a major collaboration deal.
A heavyweight Asian conglomerate will roll out its products on that continent.
- 10 stocks we like better than Grail ›
Highly specialized healthcare diagnostics company Grail (NASDAQ: GRAL) passed muster on the stock exchange on the second-to-last trading day of the week. That was on the back of news that the company has found financial backers for a push into new markets. Ultimately the stock closed the day more than 14% in positive territory, contrasting well with the S&P 500 index's 0.6% slide.
110 million reasons to be bullish
Before market open, Grail divulged it has signed a binding letter of intent with two specialized units of Korean tech giant Samsung to bring a key product to Asian markets. The arrangement also includes an investment commitment.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Image source: Getty Images.
Specifically, Samsung C&T and Samsung Electronics will commercialize Grail's Galleri multicancer early detection (MCED) diagnostic products to certain countries on their native continent. This certainly includes Samsung's home of South Korea, while Japan and Singapore were mentioned as possible future targets for the product.
The two Samsung divisions will also together invest $110 million into Grail. They are paying $70.50 per each of the company's common shares for this, which would give the pair more than 1.56 million shares.
Expanding its footprint
In its press release trumpeting this potentially lucrative deal, Grail quoted its president of international business and biopharma, Harpal Kumar, as saying that the investment portion of it "strengthens our balance sheet and provides further cash runway as we advance through key milestones to secure reimbursement for Galleri in the U.S. and key international markets."
Should you invest $1,000 in Grail right now?
Before you buy stock in Grail, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Grail wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $648,924!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,102,333!*
Now, it’s worth noting Stock Advisor’s total average return is 1,052% — a market-crushing outperformance compared to 190% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of October 13, 2025
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Grail. The Motley Fool has a disclosure policy.
Recommended Articles
